# RIVASTIGMINE
> **ANDA209063** · Abbreviated New Drug Application (Generic) · Sponsor: BRECKENRIDGE · Approved 2019-11-26
## Drug
- **FDA Application Number:** ANDA209063
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVASTIGMINE
- **Generic name:** RIVASTIGMINE
- **Active ingredients:** RIVASTIGMINE
- **Dosage form:** FILM, EXTENDED RELEASE
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** BRECKENRIDGE
- **Manufacturer:** Breckenridge Pharmaceutical, Inc.
- **First approval:** 2019-11-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209063)
---
*AI Analytics · CC0 1.0*